A small molecule targeting the multifactorial nature of Alzheimer's disease

被引：169

作者：

Cavalli, Andrea

Bolognesi, Maria Laura

Capsoni, Simona

Andrisano, Vincenza

Bartolini, Manuela

Margotti, Elisa

Cattaneo, Antonino

Recanatini, Maurizio

Melchiorre, Carlo

机构：

[1] Univ Bologna, Dept Pharmaceut Sci, Alma Mater Studiorum, I-40126 Bologna, Italy

[2] Lay Line Genom, I-00128 Rome, Italy

来源：

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2007年 / 46卷 / 20期

关键词：

amyloid beta; drug design; neurochemistry; neurodegeneration;

D O I：

10.1002/anie.200700256

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

(Figure Presented) Sights set on a cure: Memoquin (1) affects several mechanisms relevant to Alzheimer's disease (AD): the formation of reactive oxygen species, the processing and aggregation of amyloid β (Aβ) peptides, and acetylcholinesterase activity. In animal models, 1 causes a remarkable decrease in the formation of AD neurodegenerative hallmarks and a significant reversal of behavioral deficits. hAChE, BACE-1, and NQO1 are enzymes targeted by 1. © 2007 Wiley-VCH Verlag GmbH & Co. KGaA.

引用

收藏

页码：3689 / 3692

页数：4

相关论文

共 27 条

[1] β-amyloid aggregation induced by human acetylcholinesterase:: inhibition studies [J].

Bartolini, M ;

Bertucci, C ;

Cavrini, V ;

Andrisano, V .

BIOCHEMICAL PHARMACOLOGY, 2003, 65 (03) :407-416

[2] Lipoic acid, a lead structure for multi-target-directed drugs for neurodegeneration [J].

Bolognesi, Maria L. ;

Minarini, Anna ;

Tumiatti, Vincenzo ;

Melchiorre, Carlo .

MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (11) :1269-1274

[3] Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-β aggregation [J].

Bolognesi, ML ;

Andrisano, V ;

Bartolini, M ;

Banzi, R ;

Melchiorre, C .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (01) :24-27

[4] Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues [J].

Bolognesi, ML ;

Bartolini, M ;

Cavalli, A ;

Andrisano, V ;

Rosini, M ;

Minarini, A ;

Melchiorre, C .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (24) :5945-5952

[5] β-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies [J].

Capsoni, S ;

Giannotta, S ;

Cattaneo, A .

MOLECULAR AND CELLULAR NEUROSCIENCE, 2002, 21 (01) :15-28

[6] Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice [J].

Capsoni, S ;

Ugolini, G ;

Comparini, A ;

Ruberti, F ;

Berardi, N ;

Cattaneo, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) :6826-6831

[7]

CAPSONI S, 2002, BRAIN AGING, V2, P24

[8] On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease. [J].

Simona Capsoni ;

Antonino Cattaneo .

Cellular and Molecular Neurobiology, 2006, 26 (4) :619-633

[9] Secretases as targets for the treatment of Alzheimer's disease: the prospects [J].

Dewachter, I ;

Van Leuven, F .

LANCET NEUROLOGY, 2002, 1 (07) :409-416

[10] Anti-amyloidogenic activity of tetracyclines: studies in vitro [J].

Forloni, G ;

Colombo, L ;

Girola, L ;

Tagliavini, F ;

Salmona, M .

FEBS LETTERS, 2001, 487 (03) :404-407